Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Flourish Research Continues Expansion with CARE Deal
Flourish Research has announced the acquisition of the Center for Advanced Research & Education (CARE) based in Gainesville, Georgia. CARE is a multi-therapeutic research facility dedicated to advancing innovation in healthcare through conducting phase I-IV clinical trials. Founded in 1998, CARE has conducted more than 150 clinical trials across multiple therapeutic areas. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish has conducted more than 3,700 trials across more than 15 therapeutic areas and more... Read More »
Big Sky Medical Acquires Rockwall, Texas Medical Outpatient Building
Big Sky Medical, based in Dallas, Texas, announced on May 6 that it purchased a medical outpatient building (MOB) in Rockwall, Texas. The MOB, called Lake Pointe Medical Plaza, comprises 46,359 square feet and is located on the campus of Baylor Scott & White Medical Center – Lake Pointe. It comprises two buildings and houses a diverse mix of medical tenants, including Baylor Scott & White affiliates. Big Sky Medical is a national real estate investment management firm that invests in healthcare-related real estate, with a concentration in the medical outpatient and life science sectors. The firm, which is headquartered in Dallas, has more than $2 billion in healthcare... Read More »
Labcorp to Acquire Incyte Diagnostics’ Clinical Testing Business Assets
Labcorp entered into an agreement with Incyte Diagnostics to acquire select assets of its clinical testing business, including multiple same-day testing labs. The agreement also includes select technical assets of Incyte Diagnostics’ anatomic pathology (AP) business, such as its main AP laboratory in Spokane, Washington, and labs in Tukwila and Richland, Washington, and Missoula, Montana. LabCorp, an S&P 500 company, is a global life sciences company that is integrated with guiding patient care, providing clinical laboratory and end-to-end drug development services. The company provides information to help doctors, hospitals, pharmaceutical companies, researchers and patients make... Read More »
Novant Health Acquires Spine & Scoliosis Specialists
Novant Health, based in Winston-Salem, North Carolina, announced that it entered into an agreement to acquire Spine & Scoliosis Specialists. Spine & Scoliosis Specialists provides spine care from two locations in the Greensboro, North Carolina MSA. According to its website, there are three physicians on staff who are supported by a team of four. Novant Health is a not-for-profit integrated system of more than 850 locations, including 19 hospitals, more than 700 physician clinics and urgent care centers, outpatient facilities and imaging and pharmacy services. In 2024, it reported revenue of $10.2 billion. This transaction represents Novant Health’s fifth... Read More »
ENT Partners Buys RCM Firm Currence Physician Solutions
ENT Partners, a portfolio company of Boston, Massachusetts-based Candescent Partners, announced that it has acquired Seattle, Washington-based Currence Physician Solutions. Currence Physician Solutions is focused on revenue cycle management (RCM) and financial analytics. The company offers a comprehensive suite of services that encompass all aspects of the medical billing process, including denial management, coding, patient billing, payer credentialing, collections and RCM. ENT Partners is a leading network of ear, nose and throat and sleep providers. ENT Partners has achieved strong traction in the U.S. market and is focused on building on this momentum by rapidly scaling its... Read More »
NexPhase Capital Acquires Behavior Frontiers
NexPhase Capital announced on May 5 that it entered into an agreement with Behavior Frontiers. Under the terms of the agreement, Behavior Frontiers will become a subsidiary of NexPhase Capital. Founded in 2004, Behavior Frontiers is a provider of applied behavior analysis treatment services for individuals with autism and other special needs. It is based in El Segundo, California and operates 26 centers across 12 states. Behavior Frontiers was established to bring consistent care backed by cutting-edge research and data-driven practices to individuals with autism across all age groups. It has a particular emphasis on early intervention care for children between the ages of 3 to 6... Read More »
Concentra Acquires Kronos
On May 2, Concentra Biosciences reported that it acquired Kronos Bio, Inc. for $34.7 million. As of April 30, 2025, there were 60,969,214 Kronos common stock shares. At a price of $0.57 per share, the total purchase price is nearly $34.8 million. Kronos Bio is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases. Kronos Bio has a research facility in East Cambridge, Massachusetts. Concentra Biosciences is owned by Tang Capital Partners, a life sciences-focused investment company. The company was founded in 1979. Concentra will acquire Kronos’... Read More »
Healthcare M&A Heats Up in April
As anticipated by advisors and industry professionals, deal activity in the healthcare M&A market began to accelerate in April 2025. According to data captured in the LevinPro HC database, there were 184 healthcare transactions reported in April. This is up 34% from March 2025 when 137 acquisitions were announced, and 8% from April 2024, which saw 170 deals. With the conclusion of April, there have been a total of 687 healthcare deals announced since January 1, 2025, compared with 677 transactions announced during the first four months of 2024. The most active sector was Physician Medical Groups (PMG) with 41 transactions in April, marking a slight decrease from the 44 PMG deals... Read More »
